Request a quote by adding to cart
Search assays by targets
Allplex™ 2019-nCoV Assay has an Emergency Use Authorization in the US. Novaplex™ is for Research Use Only. Not for Use in Diagnostic Procedures.
-
Targets
- Mycobacterium tuberculosis (MTB)
- RIF-R (18 mutations in rpoB)
- INH-R (4 mutations in katG)
- INH-R (3 mutations in inhA promoter)
-
Targets
- Mycobacterium tuberculosis (MTB)
- RIF-R (18 mutations in rpoB)
- INH-R (4 mutations in katG)
- INH-R (3 mutations in inhA promoter)
-
Targets
- Mycobacterium tuberculosis (MTB)
- Extensive drug resistance (13 mutations)
- Injectable drug-resistance (6 mutations)
- Fluoroquinolone-resistance (7 mutations)